13029-73-7,
2-(4-Bromophenylsulfonamido)acetic acid,
2-{[(4-Bromophenyl)sulfonyl]amino}acetic acid,
2-[(4-bromophenyl)sulfonylamino]acetic acid,
Glycine,N-[(4-bromophenyl)sulfonyl]-,
2-(4-bromobenzenesulfonamido)acetic acid,
2-[[(4-Bromophenyl)sulfonyl]amino]acetic acid,
2-([(4-BROMOPHENYL)SULFONYL]AMINO)ACETIC ACID,
n-(4-bromobenzenesulphonyl)glycine,
AC1LEKDR,
ACMC-1C0PP,
AC1Q6TV3,
Oprea1_173746,
Oprea1_535511,
AE-641/08496004,
bromophenylsulfonylaminoaceticacid,
CTK4B6629,
KS-00001SPA,
DTXSID40353244,
ZINC167607,
4-bromobenzenesulfonamidoacetic acid,
N-[(4-bromophenyl)sulfonyl]glycine,
ANW-19174,
MFCD01935943,
STL480894,
AKOS000117275,
N-(4-Bromobenzene-1-sulfonyl)glycine,
AB10555,
MCULE-9814832921,
RP15888,
Glycine, N-[(4-bromophenyl)sulfonyl]-,
NCGC00341296-01,
12G-419S,
AJ-16693,
TR-004130,
{[(4-bromophenyl)sulfonyl]amino}acetic acid,
FT-0680064,
ST51042993,
Z9495,
2-[(4-bromophenyl)sulfonylamino]ethanoic acid,
B-3086,
AB01331703-02,
A806096,
SR-01000480134,
I04-1809,
J-505927,
SR-01000480134-1,
Z45658530,
2-([(4-bromophenyl)sulfonyl]amino)acetic acid, AldrichCPR,
C8H8BrNO4S,
AR-1J8961,
CID737467,
13052-09-0,